Supplements Last reviewed: June 22, 2026

Does L-theanine reduce anxiety?

Moderate Evidence
Confidence Score 60%
⚖️

IT DEPENDS

Moderate evidence supports L-theanine for reducing situational anxiety and promoting relaxation without sedation. Multiple RCTs show increased alpha brain wave activity and reduced stress markers, though long-term clinical anxiety disorder evidence is limited.

The Verdict

Moderate evidence supports L-theanine for reducing situational anxiety and promoting relaxation without sedation. Multiple RCTs show increased alpha brain wave activity and reduced stress markers, though long-term clinical anxiety disorder evidence is limited.

What the Evidence Shows

L-theanine is an amino acid found primarily in green tea that crosses the blood-brain barrier and promotes relaxation through multiple mechanisms: increasing alpha brain wave activity (associated with calm alertness), modulating GABA and serotonin levels, and reducing cortisol response to acute stress. Multiple randomized controlled trials demonstrate that 200-400mg of L-theanine reduces subjective anxiety and physiological stress markers (heart rate, cortisol, salivary immunoglobulin A) during acute stress tasks. A 2019 systematic review of 9 studies found consistent anxiolytic effects in healthy adults facing stressful situations. EEG studies reliably show increased alpha wave activity within 30-60 minutes of ingestion. However, important limitations exist: most studies measure acute situational stress responses in healthy volunteers, not chronic anxiety disorders. Evidence for generalized anxiety disorder, social anxiety, or panic disorder is minimal. The effect size is modest—L-theanine promotes calm focus rather than providing strong anxiolytic effects comparable to medications. Its gentle mechanism makes it well-tolerated with essentially no side effects, but this also means effects may be insufficient for clinical anxiety. Combined with caffeine, L-theanine appears to reduce caffeine's jittery effects while preserving alertness.

Evidence Quality

1

Meta-Analyses

9

RCTs

3

Observational

Important Caveats

  • ⚠️ Most studies examine acute situational stress, not clinical anxiety disorders
  • ⚠️ Effect sizes are modest compared to pharmaceutical anxiolytics
  • ⚠️ Limited evidence for long-term use beyond 8 weeks
  • ⚠️ Benefits may be most noticeable in combination with caffeine

Population Studied

Healthy adults aged 18-55 experiencing situational stress; students during exams; limited data in clinical anxiety populations

Dosage

200-400mg daily; acute anxiolytic effects with single 200mg dose; often combined with 100mg caffeine for synergistic effects

Duration

Acute effects within 30-60 minutes; chronic supplementation studies lasted 4-8 weeks

Supporting Studies (2)

Effects of L-theanine on anxiety: a systematic review and meta-analysis of randomized controlled trials

Meta-Analysis

Everett JM, Gunathilake D, Dufficy L, et al. · Nutrients (2019)

Systematic review of 9 RCTs found L-theanine significantly reduced stress and anxiety in adults exposed to stressful conditions, with effects on both subjective ratings and physiological markers.

View paper (DOI) →

L-Theanine reduces psychological and physiological stress responses

RCT

Kimura K, Ozeki M, Juneja LR, Ohira H. · Biological Psychology (2007)

200mg L-theanine reduced heart rate and salivary immunoglobulin A responses to an acute stress task and reduced subjective anxiety ratings compared to placebo in 12 participants.

View paper (DOI) →

Contradicting Studies (1)

L-theanine as an adjunctive therapy for generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial

RCT

Sarris J, Byrne GJ, Cribb L, et al. · Journal of Psychiatric Research (2019)

L-theanine (450-900mg/day) for 8 weeks did not significantly improve anxiety symptoms compared to placebo in 46 adults with diagnosed generalized anxiety disorder.

Why this disagrees:

While L-theanine reduces situational stress in healthy people, it may be insufficient for clinical anxiety disorders where stronger neurochemical interventions are needed. The mild mechanism may not address pathological anxiety.

View paper (DOI) →
Share:
Was this helpful?

Related Claims